Advair Pediatric Once-Daily

Summary

Advair Pediatric Once-Daily is a clinical trial^[1].

Key Facts

• Advair Pediatric Once-Daily is located in Puerto Rico^[2].
• Advair Pediatric Once-Daily is in the country of Argentina^[3].
• Advair Pediatric Once-Daily is in the country of Chile^[4].
• Advair Pediatric Once-Daily is in the country of Peru^[5].
• Advair Pediatric Once-Daily is in the country of United States^[6].
• Advair Pediatric Once-Daily's instance of is recorded as clinical trial^[7].
• Advair Pediatric Once-Daily's start time is recorded as +2001-11-30T00:00:00Z^[8].
• Advair Pediatric Once-Daily's end time is recorded as +2004-01-31T00:00:00Z^[9].
• Advair Pediatric Once-Daily's sponsor is recorded as GSK^[10].
• Advair Pediatric Once-Daily's main subject is recorded as asthma^[11].
• Advair Pediatric Once-Daily's number of participants is recorded as {'unit': '1', 'amount': '+908'}^[12].
• Advair Pediatric Once-Daily's title is recorded as A Stratified, Randomized, Double-blind, Placebo-controlled, Parallel-group, 12 Week Trial Evaluating the Safety and Efficacy of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg Once Daily Versus Fluticasone Propionate DISKUS 100mcg Once Daily and Placebo in Symptomatic Pediatric Subjects (4-11 Years) With Asthma^[13].
• Advair Pediatric Once-Daily's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+4'}^[14].
• Advair Pediatric Once-Daily's ClinicalTrials.gov ID is recorded as NCT00920959^[15].
• Advair Pediatric Once-Daily's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+11'}^[16].
• Advair Pediatric Once-Daily's research intervention is recorded as salmeterol xinafoate^[17].
• Advair Pediatric Once-Daily's clinical trial phase is recorded as phase III clinical trial^[18].
• Advair Pediatric Once-Daily's research site is recorded as GSK^[19].
• Advair Pediatric Once-Daily's study type is recorded as interventional study^[20].